	Maximal radial distance for predicting extraprostatic extension of prostate cancer: a histopathological-radiological study. Cancer Imaging Porões F, Nobile A, Widmer L, Vidal J, Di Vincenzo J, Najberg H, Fer F, El Kaïm A, Rüegg C, Froehlich JM, Reischauer C, Thoeny HC. PMID: 41723534 [PubMed - as supplied by publisher]
	Effectiveness of patient-reported outcome-based symptom monitoring after prostate cancer surgery: protocol for a multicenter, randomized controlled trial. Trials Hu S, Wang C, Gu T, Pan Y, Yu Q, Gao J, Peng F, Chen T, Li J. PMID: 41723520 [PubMed - as supplied by publisher]
	Advances in spatial omics for the analysis of prostate cancer. Anal Bioanal Chem Xu J, Wang D, Di X, Liu Y. PMID: 41723338 [PubMed - as supplied by publisher]
	Progression-free survival with darolutamide and docetaxel vs. androgen receptor pathway inhibitors vs. docetaxel in metastatic hormone-sensitive prostate cancer: A real-world multicenter retrospective study. Urol Oncol Rinderknecht E, Bielstein G, Cathomas R, Schlack K, Bastian JLD, Darr C, Unland-Gies D, Kappler P, Paffenholz P, Richter J, Müller M, Seitz AK, Steinestel J, Heidegger I, Burger M, Breyer J, Schnabel MJ. PMID: 41722488 [PubMed - as supplied by publisher]
	Neoadjuvant Therapy in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer: Recent Progress, Challenges, and Future Directions in the Era of TAR-200 and Enfortumab Vedotin Plus Pembrolizumab. Oncol Ther Di Lorenzo G, Di Maio M, Buonerba C. PMID: 41722015 [PubMed - as supplied by publisher]
	Telesurgery in prostate cancer: a systematic review of clinical applications and future directions. Prostate Cancer Prostatic Dis Aksakal B, Soputro NA, Al-Bayati A, Secin M, Autorino R, Kaouk J, Olivares R. PMID: 41721057 [PubMed - as supplied by publisher]
	Mechanistic insights and clinical implications of RNA-binding proteins in prostate cancer. Discov Oncol Javankiani S, Khodarahmi M, Yarahmadi F, Mirzohreh ST, Soltani Moghadam S, Kavousinia P, Moradi S, Aghajamal Avval N, Baghdadi M, Sargazi Moghaddam N, Khanlari Goodarzi M, Zamen Milani N, Ahmadi Beni F, Behfar Q. PMID: 41721034 [PubMed - as supplied by publisher]
	ESR Essentials: MRI-based T-staging in prostate cancer-practice recommendations by the European Society of Urogenital Radiology. Eur Radiol Agrotis G, Jäderling F, Lakhani A, Moreira ASL, Kekelidze M, Rembak-Szynkiewicz J, Logager V, Thoeny H, Villeirs G, Woo S, Schoots IG. PMID: 41720935 [PubMed - as supplied by publisher]
	Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological Outcomes. Eur Urol Oncol Longoni M, Scilipoti P, De Angelis M, Zaurito P, Tremolada G, Santangelo A, Simone G, Mastroianni R, Lonati C, Zamboni S, Suardi N, Marcq G, Szostek A, Velasco JC, Lafuente Puentedura A, Subiela JD, Del Olmo Durán P, , Karakiewicz PI, Pradere B, Soria F, Gontero P, Rouprêt M, Montorsi F, Salonia A, Briganti A, Moschini M, European Association of Urology. PMID: 41720695 [PubMed - as supplied by publisher]
	Prostate Cancer Care for Men with an Intellectual Disability: A Population-based Cohort Study of Symptoms, Diagnosis, Treatment, and Survival. Eur Urol Oncol Kennedy OJ, Chauhan U, Gorman L, Lorigan P, Merriel SWD, Staa TV, Wright A, Ashcroft DM. PMID: 41720694 [PubMed - as supplied by publisher]
	Prognostic Nomograms and Scoring System: Novel Approaches to Forecast Overall Survival and Cancer-Specific Survival in Patients With Testicular Cancer. Cancer Med Huang X, Zhu L, Sun M, Zhou Y, Ding Y, Lin C. PMID: 41720484 [PubMed - indexed for MEDLINE]
	Cabozantinib plus nivolumab and ipilimumab in previously untreated, advanced renal cell carcinoma: final results and biomarker analyses from the phase III COSMIC-313 study. Ann Oncol Motzer RJ, Albiges L, Aguirre SAT, Kanesvaran R, Centkowski P, Reimers MA, Sade JP, Pouessel D, Biscaldi E, Esteban E, Arranz Arija JÁ, Tykodi SS, van Kooten Losio M, Dighe A, Ma H, Valmeekam V, Simmons A, Scheffold C, Andrianova S, Braun DA, Powles T, Choueiri TK. PMID: 41720427 [PubMed - as supplied by publisher]
	Listening to the bladder field: Urine liquid biopsies reveal differential treatment responses in NMIBC. Cell Jonas K, Moser T, Heitzer E. PMID: 41720073 [PubMed - indexed for MEDLINE]
	Evaluation, Optimization, and Validation of a Multiparametric CT Algorithm for Solid Renal Masses: CT-Score Version 2.0. Radiol Imaging Cancer Krishna S, Kandasamy M, Bhayana R, Nanda B, Diwan K, Kamona A, Sairafi S, Prendeville S, Deng Y, Finelli A, Davenport MS, Schieda N. PMID: 41718533 [PubMed - indexed for MEDLINE]
	Ciprofloxacin Versus Fosfomycin for Empirical Prophylaxis Before Transrectal Prostate Biopsy: Clinical, Microbiological, and Patient-Reported Outcomes from a Prospective Study. Med Sci (Basel) Burzinskis E, Janulaityte I, Burzinskiene G, Skaudickas D, Naudziunas A, Vitkauskiene A. PMID: 41718138 [PubMed - indexed for MEDLINE]
	Diagnostic Accuracy of PSMA-PET/CT vs. mpMRI in Primary Staging of Intermediate- and High-Risk Prostate Cancer. Med Sci (Basel) Talavera Cobo V, Yánez Ruiz CA, Tapia Tapia MD, Calva Lopez A, Muñoz Bastidas CA, Ancizu Marckert FJ, Torres Roca M, Huerta LL, Sanchez Zalabardo D, Diez-Caballero Alonso FJ, Guillen-Grima F, Robles García JE, Miñana-López B. PMID: 41718112 [PubMed - indexed for MEDLINE]
	Erectile Dysfunction and Its Impact on Health-Related Quality of Life in Prostate Cancer Patients: A Multicenter Cross-Sectional Study from Pakistan. Epidemiologia (Basel) Abbas M, Gajdács M, Balogh G, Ahmed S, Mahfooz R, Khan A. PMID: 41718049 [PubMed]
	Network pharmacology research integrating LC-MS/MS, machine learning, molecular docking, and dynamics simulation: key biomarkers and potential mechanisms of Phellinus igniarius against prostate cancer. In Silico Pharmacol Ren Z, Liu X, Zhang J, Song M, Yang Q, Li C, Liu D. PMID: 41717432 [PubMed]
	Positive predictive value of the prostate imaging reporting and data system combined with single related indicators in prostate cancer across different prostate zones. Front Oncol Shen X, Yang L, Wang S, Shen J. PMID: 41717420 [PubMed]
	Advancing CAR-T therapy in prostate cancer: overcoming the tumor microenvironment and enhancing efficacy. Front Oncol Zhou Z, Lao Y, Zhao K, Cheng L, Xiao X, Li W, Liu S, Kong X, Dong Z. PMID: 41717407 [PubMed]

Articles 1 - 20 / 176186

Page 1 of 8810



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy